Laparoscopic hysterectomy for persistent gestational trophoblastic neoplasia.
We performed laparoscopic hysterectomy in a woman with persistent gestational trophoblastic neoplasia. The procedure offered advantages over vaginal hysterectomy in that intraabdominal inspection was possible, morcellation was avoided, and the uterine arteries were transected before uterine manipulation to avoid potential tumor embolization. In addition, an abdominal incision was not required, and the patient had shorter hospitalization and less pain than she would have had with the standard abdominal procedure. Persistent, locally invasive gestational trophoblastic neoplasia (GTN) develops in 15% of women after dilatation and evacuation for molar pregnancy. Chemotherapy and hysterectomy are curative in virtually all patients. Numerous factors are considered in deciding the primary mode of therapy. Women in whom fertility is not an issue may choose hysterectomy, which decreases the amount of chemotherapy required to achieve cure. Traditionally, this has been performed with an abdominal approach. We performed laparoscopic hysterectomy to manage GTN.
Lang
J F
JF
Department of Obstetrics and Gynecology, University of Arizona, 1501 North Campbell Avenue, Tucson, AZ 85724, USA.
Childers
J M
JM
Surwit
E A
EA
D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001158:Arteries / Q000601:surgery; D003131:Combined Modality Therapy; D004107:Dilatation and Curettage; D005260:Female; D006760:Hospitalization; D006801:Humans; D006828:Hydatidiform Mole / Q000188:drug therapy / Q000601:surgery; D007044:Hysterectomy / Q000295:instrumentation / Q000379:methods; D020706:Laparoscopes; D010535:Laparoscopy / Q000379:methods; D007902:Length of Stay; D009361:Neoplasm Invasiveness; D009360:Neoplastic Cells, Circulating; D011247:Pregnancy; D013528:Surgical Staplers; D014328:Trophoblastic Neoplasms / Q000188:drug therapy / Q000601:surgery*; D014594:Uterine Neoplasms / Q000188:drug therapy / Q000601:surgery*; D014599:Uterus / Q000098:blood supply
D000970:Antineoplastic Agents